StockSignal
  • Screen for fundamentally interesting stocks
Sign in
Shandong Weigao Orthopaedic Device Co., Ltd. logo

Shandong Weigao Orthopaedic Device Co., Ltd.

688161 · XSHG · Medical Devices · China

Market Capitalization11.82B CNY
Trailing P/E46.70 CNY
52-Week Change4.30 CNY
Forward Annual Dividend Yield0.68%
Beta0.5460 CNY

Shandong Weigao Orthopaedic Device Co., Ltd. is a prominent manufacturer within the medical device industry, specializing in the development and production of orthopedic equipment. Catering to a critical segment of the healthcare sector, the company supplies innovative solutions for bone repair surgeries and musculoskeletal disorder treatments. Its comprehensive product portfolio spans spinal implants, joint replacements, and trauma devices, effectively addressing the diverse needs of hospitals and surgical centers. By investing in research and development, Shandong Weigao Orthopaedic Device Co., Ltd. consistently integrates advanced technologies to enhance product efficacy and user outcomes. Occupying a vital role in China’s burgeoning medical device market, the company supports the healthcare infrastructure by providing essential products that enable better patient care and improved surgical results. Its commitment to quality and precision contributes significantly to the advancements in the orthopedic field, demonstrating its importance as a key player in medical innovation and service provision.

Industry

Medical Devices

Healthcare sector · China

Stories

Structural patterns identified in Shandong Weigao Orthopaedic Device Co., Ltd.

No stories identified yet.

Key Metrics

Market Capitalization
11.82BCNY
NormalMar 19, 2026
Trailing P/E
46.70CNY
AboveNormalMar 19, 2026
Revenue (TTM)
1.54BCNY
NormalMar 19, 2026
Profit Margin
17.32%
NormalMar 19, 2026
Beta
0.5460CNY
NormalMar 19, 2026
52-Week Change
4.30CNY
ExtremeMar 19, 2026
Forward Annual Dividend Yield
0.68%
NormalMar 19, 2026
Forward Yield
0.68%
Annual Rate
CNY 0.20
Paid semi-annual
Payout Ratio
43.3%
Sustainable
Loading dividend history...

Track Record

Frequency
Semi-Annual
Payback Period
115.6 yr
Years to recoup investment via dividends alone

Upcoming

Ex-Dividend Date
Oct 21, 2025

Screen for dividend patterns

Find other stocks with similar dividend characteristics in the screener.

Dividend Fortress
→
dividend consistency
dividend quality
free cash flow conversion
Open in Screener
Dividend Growth Track
→
dividend growth rate
dividend streak
dividend consistency
Open in Screener
Dividend Sustainability
→
dividend quality
common dividends to free cash flow
dividend stress
Open in Screener
Valuation7
Market Capitalization
11.82BCNY
NormalMar 19, 2026
Enterprise Value
10.58BCNY
NormalMar 19, 2026
Trailing P/E
46.70CNY
AboveNormalMar 19, 2026
Price to Sales (TTM)
8.13CNY
NormalMar 19, 2026
Price to Book (MRQ)
3.05CNY
NormalMar 19, 2026
Enterprise to Revenue
6.87CNY
NormalMar 19, 2026
Enterprise to EBITDA
28.18CNY
NormalMar 19, 2026
Profitability & Growth19
Gross Margin
68.32%
NormalMar 19, 2026
Profit Margin
17.32%
NormalMar 19, 2026
Operating Margin
18.08%
NormalMar 19, 2026
Return on Assets (TTM)
0.0452CNY
NormalMar 19, 2026
Return on Equity (TTM)
0.0663CNY
NormalMar 19, 2026
Revenue (TTM)
1.54BCNY
NormalMar 19, 2026
Revenue per Share (TTM)
3.87CNY
NormalMar 19, 2026
Quarterly Revenue Growth
0.1720CNY
NormalMar 19, 2026
Gross Profit (TTM)
1.54BCNY
NormalMar 19, 2026
EBITDA
377.87MCNY
ExtremeMar 19, 2026
Net Income (TTM)
266.64MCNY
NormalMar 19, 2026
Quarterly Earnings Growth (YoY)
-0.0040CNY
NormalMar 19, 2026
Operating Cash Flow (TTM)
321.59MCNY
NormalMar 19, 2026
Levered Free Cash Flow (TTM)
223.75MCNY
NormalMar 19, 2026
Forward Annual Dividend Rate
0.2000CNY
NormalMar 19, 2026
Forward Annual Dividend Yield
0.68%
NormalMar 19, 2026
Trailing Annual Dividend Rate
0.2700CNY
NormalMar 19, 2026
Trailing Annual Dividend Yield
0.91%
NormalMar 19, 2026
Payout Ratio
0.4328CNY
NormalMar 19, 2026
Financial Strength10
Shares Outstanding
400.00MShares
NormalMar 19, 2026
Float Shares
67.23MCNY
NormalMar 19, 2026
% Held by Insiders
0.8565CNY
AboveNormalMar 19, 2026
% Held by Institutions
0.0111CNY
NormalMar 19, 2026
Total Cash (MRQ)
1.83BCNY
NormalMar 19, 2026
Total Cash per Share (MRQ)
4.62CNY
NormalMar 19, 2026
Total Debt (MRQ)
2.61MCNY
NormalMar 19, 2026
Total Debt to Equity (MRQ)
0.0640CNY
NormalMar 19, 2026
Current Ratio (MRQ)
5.00CNY
AboveNormalMar 19, 2026
Book Value per Share (MRQ)
10.25CNY
NormalMar 19, 2026
Market & Technical9
52-Week Low
24.68CNY
NormalMar 19, 2026
52-Week High
37.30CNY
NormalMar 19, 2026
52-Week Change
4.30CNY
ExtremeMar 19, 2026
Beta
0.5460CNY
NormalMar 19, 2026
50-Day MA
30.03CNY
NormalMar 19, 2026
200-Day MA
29.83CNY
NormalMar 19, 2026
Avg 10-Day Volume
2.55MCNY
NormalMar 19, 2026
Avg 30-Day Volume
1.66MCNY
NormalMar 19, 2026
Diluted EPS (TTM)
0.6700CNY
NormalMar 19, 2026

Coordination

Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination

Supply Chain

Medical Devices Supply Chain

The medical devices supply chain is shaped by three structural constraints that most manufacturing industries do not face: a regulatory classification cascade where risk level determines the years of validation required before a product can be sold, sterilization and biocompatibility requirements that restrict which materials and processes are permitted, and installed base dependency where hospitals commit to ecosystems that cannot be switched without replacing training, consumables, and data infrastructure.

StockSignal
  • Blog
  • Industries
  • Glossary
  • Stories
  • Coordinations
  • Constraint Archetypes
  • Legal

Contact

© 2026 StockSignal. All rights reserved.